IMR Press / FBL / Volume 21 / Issue 5 / DOI: 10.2741/4430

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Progress in research and application of PLGA embolic microspheres

Show Less
1 Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, China
2 Institute of Medical Intervention Engineering, Tongji University, Shanghai, 200072, China
Academic Editor:Xu Jin
Front. Biosci. (Landmark Ed) 2016, 21(5), 931–940;
Published: 1 June 2016
(This article belongs to the Special Issue The dual role of ERK signaling in the apoptosis of neurons)

Transcatheter arterial chemoembolization was an important method in the treatment of solid cancers and the effectiveness of such treatment depends on the nature of embolic agent. Due to the biocompatibility, controllable degradation rate, and both hydrophobicity–hydrophilicity, researches of application on poly(lactic-co-glycolic acid) (PLGA) in medical practice has been ongoing for more than 40 years. We have seen many benefits for patients in recent years. There were five different methods of preparing micrometer-scale microspheres, and three kinds of PLGA microspheres have been subjected to experimental research or used in clinical applications, namely blank microspheres, drug-loaded microspheres, and radioactive microspheres. Hereby, we reviewed the production and clinical and experimental applications of PLGA microspheres in practice.

Back to top